|1.||O'Neill, Michael J: 1 article (08/2012)|
|2.||Duty, Susan: 1 article (08/2012)|
|3.||Betts, Matthew J: 1 article (08/2012)|
|4.||Kalloniatis, Michael: 1 article (11/2007)|
|5.||Bui, Bang V: 1 article (11/2007)|
|6.||Sun, Daniel: 1 article (11/2007)|
|7.||Vingrys, Algis J: 1 article (11/2007)|
|8.||Pepperberg, David R: 1 article (03/2007)|
|9.||Saszik, Shannon M: 1 article (03/2007)|
|10.||Frishman, Laura J: 1 article (03/2007)|
|1.||Ganglion Cysts (Ganglion)
02/01/1995 - "1. In this report we describe extracellular recordings made from directionally selective (DS) ganglion cells in the rabbit retina during perfusion with 2-amino-4-phosphonobutyric acid (APB) to block ON channels through the retina. "
03/01/1994 - "In contrast, an increase in resting firing rates was observed when L-APB was applied to some OFF-center ganglion cells. "
01/01/1983 - "The effects of 2-amino-4-phosphonobutyric acid (APB) on the ERG and ganglion cell discharge of rabbit retina."
01/09/1981 - "When intracellular electrophysiological recordings were obtained from the perfused retina-eyecup preparation of the mud-puppy (Necturus maculosus), the addition of 2-amino-4-phosphonobutyric acid to the bathing medium blocked all responses in the ON channel but left intact the OFF responses including OFF ganglion cell discharge. "
03/01/2007 - "Time course data also were obtained before versus after intravitreal injection of L-2-amino-4-phosphonobutyrate (APB) (which blocks transmission from photoreceptors to depolarizing bipolar cells) and of cis 2,3-piperidine dicarboxylic acid (PDA) (which blocks transmission to OFF bipolar cells, and to horizontal, amacrine and ganglion cells). "
05/01/1995 - "2-amino-5-phosphovalerate, 3-[(+/-)-2-carboxypiperazine-4-yl]-propyl-1-phosphonate or dibenzocycloheptaneimine, N-methyl-D-aspartate receptor inhibitors, abolished enhancement by tetanus, whereas, 6,7-dinitroquinoxaline-2,3-dione, an antagonist of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid ionotropic receptors, or L-2-amino-4-phosphonobutyrate, an antagonist of glutamate metabotropic receptors, showed no effect. "
|3.||Parkinson Disease (Parkinson's Disease)
08/01/2012 - "We recently reported that broad spectrum agonist-induced activation of presynaptic group III metabotropic glutamate (mGlu) receptors within the substantia nigra pars compacta using L-2-amino-4-phosphonobutyrate provided functional neuroprotection in the 6-hydroxydopamine lesion rat model of Parkinson's disease. "
07/01/1996 - "We have previously reported that 2-amino-4-phosphonobutyric acid (AP4), an agonist of presynaptically located metabotropic glutamate receptors, administrated at a single intracerebroventricular (icv) injection facilitated learning and memory in a passive- and learning in an active avoidance situation, enhanced apomorphine stereotypy, and attenuated haloperidol catalepsy in rats. "
|1.||Excitatory Amino Acid Agonists
|2.||Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)
|3.||Glutamic Acid (Glutamate)
|5.||Excitatory Amino Acids
|6.||Oxidopamine (6 Hydroxydopamine)
|9.||metabotropic glutamate receptor 4
|10.||FG 9041 (DNQX)